# Insight Molecular Diagnostics Inc. (IMDX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/IMDX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 4.15M | $ -51.42M | $ -25.98M | $ 3.50M | $ -31.46M |
| 2024 | $ 1.98M | $ -63.76M | $ -22.00M | $ 3.66M | $ -12.27M |
| 2023 | $ 1.63M | $ -30.04M | $ -24.04M | $ 2.87M | $ 20.47M |
| 2022 | $ 1.07M | $ -81.44M | $ -55.75M | $ 3.54M | $ 39.59M |
| 2021 | $ 9.18M | $ -76.19M | $ -45.39M | $ 5.68M | $ 65.22M |
| 2020 | $ 1.55M | $ -38.13M | $ -34.66M | $ 8.63M | $ 33.48M |
| 2019 | $ 0 | $ -28.95M | $ -26.63M | $ 6.17M | $ 30.84M |
| 2018 | $ 0 | $ -20.80M | $ -15.11M | $ 1.72M | $ 3.42M |
| 2017 | $ 0 | $ -26.10M | $ -18.15M | $ 2.50M | $ 4.40M |
| 2016 | $ 0 | $ -15.37M | $ -10.49M | $ 512.0K | $ 9.86M |
| 2015 | $ 0 | $ -12.26M | $ -6.64M | $ 0 | $ 10.42M |
| 2014 | $ 0 | $ -7.05M | $ -1.66M | $ 5.89M | $ -1.07M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.11 |
| Liabilities / Eq | -1.82 |
| Current Ratio | 1.27 |

## Other views

- [Metrics](https://sponda.capital/en/IMDX.md)
- [Charts](https://sponda.capital/en/IMDX/charts.md)
- [Compare](https://sponda.capital/en/IMDX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.